Asparaginase Erwinia chrysanthemi and Ranibizumab Intraocular
Determining the interaction of Asparaginase Erwinia chrysanthemi and Ranibizumab Intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: asparaginase erwinia chrysanthemi
Brand name: Erwinaze
Synonyms: Asparaginase (Erwinia)
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Asparaginase Erwinia chrysanthemi-Ranibizumab ophthalmic
- Asparaginase Erwinia chrysanthemi-Ranitidine
- Asparaginase Erwinia chrysanthemi-Ranitidine Capsule
- Asparaginase Erwinia chrysanthemi-Ranitidine Hydrochloride
- Asparaginase Erwinia chrysanthemi-Ranitidine Injection
- Asparaginase Erwinia chrysanthemi-Ranitidine Suspension
- Ranibizumab Intraocular-Asparaginase erwinia chrysanthemi Intramuscular
- Ranibizumab Intraocular-Asparlas
- Ranibizumab Intraocular-Aspercreme Lidocaine
- Ranibizumab Intraocular-Aspergum
- Ranibizumab Intraocular-Aspir 81
- Ranibizumab Intraocular-Aspir-Low